Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (19654)	4/27/1998 9:48:00 AM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

bob, Speaking of being back, while in Indianapolis, I caught the tail end of the Nightly Business Report which had 3 Biotech analysts on Friday. I just heard Maykin Ho who liked AMGN and MLNM for obesity. Did anyone catch the entire show? Who were the other analysts? What did they like and say?

To: bob zagorin who wrote (19654)	4/27/1998 9:52:00 AM
From: tonyt	Respond to of 32384

> the "dog" bop, the poodle hasn't been here since $15.

To: bob zagorin who wrote (19654)	4/29/1998 6:37:00 AM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

Anyone see yesterday's WSJ? There was a "Heard on the Street" article linked to LGND at the WSJ Interactive site, but I can't find the article, even when searching their "Heard on the Street" section. Not sure if this means LGND is to be in an upcoming "Heard on the Street" column, or there is just some kind of glitch in the WSJ Interactive site. Here's what's listed in the LGND briefing book under press releases: Ligand Pharmaceuticals Inc. Enter Symbol: 'HEARD ON THE STREET: Lions or Lemmings?' San Diego... --April 28, 1998 SmithKline Beecham and Ligand Receive Regulatory... --April 27, 1998 Ligand Reports Positive Final Results of Pivotal... --March 26, 1998 Ligand Announces Wyeth-Ayerst Submitted IND for... --March 26, 1998 SmithKline Beecham and Ligand Add Leptin-Obesity... --March 18, 1998 Ligand Pharmaceuticals Incorporated Extends Product... --March 9, 1998 Scherer Discloses Two New Softgel Products in its... --March 6, 1998 NASDAQ Investor Forum Exhibitor Profile for Ligand... --March 5, 1998 Expanded Phase I/II Data With Ligand's Panretin(TM) Gel... --March 2, 1998 Expanded Phase I/II Data With Ligand's Panretin(TM) Gel... --March 1, 1998 Ligand Pharmaceuticals Inc. Licenses Glycomed Patents... --February 24, 1998 Ligand Board of Directors Elects Victoria Fash to its... --February 23, 1998 Philip A. Duffy Named Vice President, Technical... --February 19, 1998 Ligand Pharmaceuticals Elects Marketing Vice President... --February 19, 1998 Ligand Increases Revenues by 40% and Ends Year with... --February 5, 1998